Rajesh Mohandas

Rajesh Mohandas

rajmohandas.bsky.social

Physician scientist interested in vascular biology of kidney disease. LSU Nephrology NOLA

👤 Joined on 11 November 2024

856

Followers

565

Following

4

Total Posts

📜 Kullanıcı Geçmişi

  • 11 Kas 2024, 20:26
    🎉 Bluesky'e katıldı - İlk kullanıcı adı: @rajmohandas.bsky.social

🚫 Blokladığı Kullanıcılar

❤️ Beğendiği Gönderiler

I’m deeply honored to be elected to the @nam.edu . This story begins with Hilda, a patient who could only get dialysis in the ER because she was undocumented, and the coalition that changed that policy in Colorado and 20+ states. @cuanschutz.bsky.social

Show Post

As a 2026 top 5 #ASNJASN reviewer, Dr. Sandeep K. Mallipattu notes “Peer review is where scientific progress meets shared purpose. It’s an opportunity for the research community to challenge, refine, and strengthen one another’s work in service of knowledge we can trust.” #PRW2026

Show Post
Eric Topol
30 September 2026 15:16

Why do our cells age? It's not just wear and tear, accumulated damage. Loss of cell identity takes center stage. A new Nature paper and connection with prior work that substantially advances the science of aging. In the new Ground Truths. erictopol.substack.com/p/loss-of-ce...

Show Post

This week we're still catching up with #ERA26 The TRACK study 🛤️🩸 #NephJC #NephSky Check out the VA by @drsaivani.bsky.social Can low dose rivaroxaban improve CV outcomes in advanced CKD? www.nephjc.com/news/2026/7/6/track-the-visual-abstract

Show Post

Boom The European Medical Agency @ema.europa.eu pulls the approval for Tavneos aka Avacopan over trial shenanigans #Vasculitis cc @kidneyboy.bsky.social @brycebarr.bsky.social

Show Post

Select language

Install App

Install App